Basit öğe kaydını göster

Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

dc.contributor.authorYUMUK, Volkan Demirhan
dc.contributor.authorSiva, Zeynep Osar
dc.contributor.authorSahin, Humeyra Rekali
dc.contributor.authorDAMCI, Taner
dc.contributor.authorIlkova, Hasan
dc.contributor.authorSahin, Serdar
dc.contributor.authorHaliloglu, Ozlem
dc.contributor.authorKorkmaz, Ozge Polat
dc.contributor.authorDURCAN, Emre
dc.date.accessioned2021-12-10T11:18:42Z
dc.date.available2021-12-10T11:18:42Z
dc.date.issued2021
dc.identifier.citationSahin S., Haliloglu O., Korkmaz O. P. , DURCAN E., Sahin H. R. , YUMUK V. D. , DAMCI T., Ilkova H., Siva Z. O. , "Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?", TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.2, ss.735-742, 2021
dc.identifier.issn1300-0144
dc.identifier.othervv_1032021
dc.identifier.otherav_759cbede-f470-4c37-89c8-bb4205f7ae42
dc.identifier.urihttp://hdl.handle.net/20.500.12627/171632
dc.identifier.urihttps://doi.org/10.3906/sag-2008-37
dc.description.abstractBackground/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).
dc.language.isoeng
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleDoes treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF MEDICAL SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume51
dc.identifier.issue2
dc.identifier.startpage735
dc.identifier.endpage742
dc.contributor.firstauthorID2635795


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster